194 related articles for article (PubMed ID: 36053534)
1. Association of Male Hypogonadism With Risk of Hospitalization for COVID-19.
Dhindsa S; Champion C; Deol E; Lui M; Campbell R; Newman J; Yeggalam A; Nadella S; Ahir V; Shrestha E; Kannampallil T; Diwan A
JAMA Netw Open; 2022 Sep; 5(9):e2229747. PubMed ID: 36053534
[TBL] [Abstract][Full Text] [Related]
2. Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism.
Grabner M; Hepp Z; Raval A; Tian F; Khera M
J Sex Med; 2018 Feb; 15(2):148-158. PubMed ID: 29425664
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data.
Alwani M; Yassin A; Talib R; Al-Qudimat A; Aboumarzouk O; Al-Zoubi RM; Saad F; Haider KS; Al Ansari A
Vasc Health Risk Manag; 2021; 17():497-508. PubMed ID: 34465997
[TBL] [Abstract][Full Text] [Related]
4. Association of Circulating Sex Hormones With Inflammation and Disease Severity in Patients With COVID-19.
Dhindsa S; Zhang N; McPhaul MJ; Wu Z; Ghoshal AK; Erlich EC; Mani K; Randolph GJ; Edwards JR; Mudd PA; Diwan A
JAMA Netw Open; 2021 May; 4(5):e2111398. PubMed ID: 34032853
[TBL] [Abstract][Full Text] [Related]
5. Hypogonadism in men with chronic pain linked to the use of long-acting rather than short-acting opioids.
Rubinstein AL; Carpenter DM; Minkoff JR
Clin J Pain; 2013 Oct; 29(10):840-5. PubMed ID: 24384986
[TBL] [Abstract][Full Text] [Related]
6. Morbidity and mortality in men: Role of androgens.
Fallara G; Pozzi E; Corsini C; Belladelli F; Boeri L; Capogrosso P; Montorsi F; Salonia A
Best Pract Res Clin Endocrinol Metab; 2022 Jul; 36(4):101662. PubMed ID: 35484028
[TBL] [Abstract][Full Text] [Related]
7. Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study.
Yassin A; Haider A; Haider KS; Caliber M; Doros G; Saad F; Garvey WT
Diabetes Care; 2019 Jun; 42(6):1104-1111. PubMed ID: 30862651
[TBL] [Abstract][Full Text] [Related]
8. Trends in Testosterone Therapy use in Prostate Cancer Survivors in the United States.
Chen T; Li S; Eisenberg ML
J Sex Med; 2021 Aug; 18(8):1346-1353. PubMed ID: 34303630
[TBL] [Abstract][Full Text] [Related]
9. Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study.
Haider A; Yassin A; Haider KS; Doros G; Saad F; Rosano GM
Vasc Health Risk Manag; 2016; 12():251-61. PubMed ID: 27366080
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Morbidity and Mortality in Men - Findings From a Meta-analysis on the Time-related Measure of Risk of Exogenous Testosterone.
Fallara G; Pozzi E; Belladelli F; Corsini C; Boeri L; Capogrosso P; Montorsi F; Salonia A
J Sex Med; 2022 Aug; 19(8):1243-1254. PubMed ID: 35753891
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism: A Real-Life Observational Registry Study Setting Comparing Treated and Untreated (Control) Groups.
Traish AM; Haider A; Haider KS; Doros G; Saad F
J Cardiovasc Pharmacol Ther; 2017 Sep; 22(5):414-433. PubMed ID: 28421834
[TBL] [Abstract][Full Text] [Related]
13. Serum testosterone levels and mortality in men with CKD stages 3-4.
Khurana KK; Navaneethan SD; Arrigain S; Schold JD; Nally JV; Shoskes DA
Am J Kidney Dis; 2014 Sep; 64(3):367-74. PubMed ID: 24726629
[TBL] [Abstract][Full Text] [Related]
14. Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms.
Saad F; Doros G; Haider KS; Haider A
Investig Clin Urol; 2018 Nov; 59(6):399-409. PubMed ID: 30402573
[TBL] [Abstract][Full Text] [Related]
15. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy.
Lundy SD; Parekh NV; Shoskes DA
J Sex Med; 2020 Jul; 17(7):1297-1303. PubMed ID: 32307242
[TBL] [Abstract][Full Text] [Related]
16. Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies.
Corona G; Rastrelli G; Di Pasquale G; Sforza A; Mannucci E; Maggi M
J Sex Med; 2018 Jun; 15(6):820-838. PubMed ID: 29803351
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores.
Corona G; Rastrelli G; Morgentaler A; Sforza A; Mannucci E; Maggi M
Eur Urol; 2017 Dec; 72(6):1000-1011. PubMed ID: 28434676
[TBL] [Abstract][Full Text] [Related]
18. Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without Hypogonadism.
Walker RF; Zakai NA; MacLehose RF; Cowan LT; Adam TJ; Alonso A; Lutsey PL
JAMA Intern Med; 2020 Feb; 180(2):190-197. PubMed ID: 31710339
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment with testosterone undecanoate injections in men with hypogonadism alleviates erectile dysfunction and reduces risk of major adverse cardiovascular events, prostate cancer, and mortality.
Saad F; Caliber M; Doros G; Haider KS; Haider A
Aging Male; 2020 Mar; 23(1):81-92. PubMed ID: 30782054
[No Abstract] [Full Text] [Related]
20. [Androgenic status in men during COVID-19].
Rozhivanov RV; Melnichenko GA; Andreeva EN; Mokrysheva NG
Probl Endokrinol (Mosk); 2022 Apr; 68(4):111-116. PubMed ID: 36104972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
